RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review
Respiratory syncytial virus (RSV) causes infections of the lower respiratory tract. A group particularly vulnerable to severe infection are young children under 2 years of age and the elderly. The infection can cause the entire spectrum of respiratory symptoms from upper respiratory tract infection...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Kazimierz Wielki University
2024-02-01
|
| Series: | Journal of Education, Health and Sport |
| Subjects: | |
| Online Access: | https://apcz.umk.pl/JEHS/article/view/48320 |
| _version_ | 1827347683647422464 |
|---|---|
| author | Paulina Dąbrowska Michał Żuber Karol Bochyński Katarzyna Molenda Katarzyna Ciuba Barbara Borodziuk Filip Borodziuk Michał Dacka Kamila Giżewska Konrad Białogłowski |
| author_facet | Paulina Dąbrowska Michał Żuber Karol Bochyński Katarzyna Molenda Katarzyna Ciuba Barbara Borodziuk Filip Borodziuk Michał Dacka Kamila Giżewska Konrad Białogłowski |
| author_sort | Paulina Dąbrowska |
| collection | DOAJ |
| description |
Respiratory syncytial virus (RSV) causes infections of the lower respiratory tract. A group particularly vulnerable to severe infection are young children under 2 years of age and the elderly. The infection can cause the entire spectrum of respiratory symptoms from upper respiratory tract infections to severe courses requiring assisted breathing. Until recently, the only form of protection against infection was passive immunization, i.e. administration of immunoglobulins. Chief among these are palivizumab and nirsevimab. In May u June 2023, the Food and Drug Administration (FDA) approved for use 2 vaccines against RSV are Arexvy and Abrysvo. In this study, we focus on presenting and describing the clinical evidence supporting the effectiveness of these immunization methods.
|
| first_indexed | 2024-03-07T23:55:30Z |
| format | Article |
| id | doaj.art-f9bd3d79a1ad43e69d6671e352d15ac6 |
| institution | Directory Open Access Journal |
| issn | 2391-8306 |
| language | English |
| last_indexed | 2024-03-07T23:55:30Z |
| publishDate | 2024-02-01 |
| publisher | Kazimierz Wielki University |
| record_format | Article |
| series | Journal of Education, Health and Sport |
| spelling | doaj.art-f9bd3d79a1ad43e69d6671e352d15ac62024-02-18T11:52:54ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062024-02-016110.12775/JEHS.2024.61.003RSV Disease Threat and Innovative Prevention Methods in Health Protection: A ReviewPaulina Dąbrowska0Michał Żuber1Karol Bochyński2Katarzyna Molenda3Katarzyna Ciuba4Barbara Borodziuk5Filip Borodziuk6Michał Dacka7Kamila Giżewska8Konrad Białogłowski9Province Specialist Hospital named after Stefan Cardinal Wyszyński in Lublin al. Kraśnicka 100, 20-718 Lublin, Poland4th Clinical University Hospital in Lublin, ul. Kazimierza Jaczewskiego 8, 20-954 Lublin, Poland4th Clinical University Hospital in Lublin, ul. Kazimierza Jaczewskiego 8, 20-954 Lublin, Poland1 Military Clinical Hospital in Lublin, al. Racławickie 23,20-049 Lublin, PolandProvince Specialist Hospital named after Stefan Cardinal Wyszyński in Lublinal. Al. Kraśnicka 100, 20-718 Lublin, Poland1 Military Clinical Hospital in Lublin, al. Racławickie 23,20-049 Lublin, Poland1 Military Clinical Hospital in Lublin, al. Racławickie 23, 20-049 Lublin, Poland1 Military Clinical Hospital in Lublin, al. Racławickie 23,20-049 Lublin, Poland1 Military Clinical Hospital in Lublin, al. Racławickie 23,20-049 Lublin, PolandUniversity Clinical Hospital No. 1 in Lublin, ul. Stanisława Staszica 16, 20-081 Lublin, Poland Respiratory syncytial virus (RSV) causes infections of the lower respiratory tract. A group particularly vulnerable to severe infection are young children under 2 years of age and the elderly. The infection can cause the entire spectrum of respiratory symptoms from upper respiratory tract infections to severe courses requiring assisted breathing. Until recently, the only form of protection against infection was passive immunization, i.e. administration of immunoglobulins. Chief among these are palivizumab and nirsevimab. In May u June 2023, the Food and Drug Administration (FDA) approved for use 2 vaccines against RSV are Arexvy and Abrysvo. In this study, we focus on presenting and describing the clinical evidence supporting the effectiveness of these immunization methods. https://apcz.umk.pl/JEHS/article/view/48320Respiratory syncytial virus (RSV)BronchitisRSV preventionPalivizumabNirsevimabRSV vaccine |
| spellingShingle | Paulina Dąbrowska Michał Żuber Karol Bochyński Katarzyna Molenda Katarzyna Ciuba Barbara Borodziuk Filip Borodziuk Michał Dacka Kamila Giżewska Konrad Białogłowski RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review Journal of Education, Health and Sport Respiratory syncytial virus (RSV) Bronchitis RSV prevention Palivizumab Nirsevimab RSV vaccine |
| title | RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review |
| title_full | RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review |
| title_fullStr | RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review |
| title_full_unstemmed | RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review |
| title_short | RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review |
| title_sort | rsv disease threat and innovative prevention methods in health protection a review |
| topic | Respiratory syncytial virus (RSV) Bronchitis RSV prevention Palivizumab Nirsevimab RSV vaccine |
| url | https://apcz.umk.pl/JEHS/article/view/48320 |
| work_keys_str_mv | AT paulinadabrowska rsvdiseasethreatandinnovativepreventionmethodsinhealthprotectionareview AT michałzuber rsvdiseasethreatandinnovativepreventionmethodsinhealthprotectionareview AT karolbochynski rsvdiseasethreatandinnovativepreventionmethodsinhealthprotectionareview AT katarzynamolenda rsvdiseasethreatandinnovativepreventionmethodsinhealthprotectionareview AT katarzynaciuba rsvdiseasethreatandinnovativepreventionmethodsinhealthprotectionareview AT barbaraborodziuk rsvdiseasethreatandinnovativepreventionmethodsinhealthprotectionareview AT filipborodziuk rsvdiseasethreatandinnovativepreventionmethodsinhealthprotectionareview AT michałdacka rsvdiseasethreatandinnovativepreventionmethodsinhealthprotectionareview AT kamilagizewska rsvdiseasethreatandinnovativepreventionmethodsinhealthprotectionareview AT konradbiałogłowski rsvdiseasethreatandinnovativepreventionmethodsinhealthprotectionareview |